Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Apr;73(4):310–319. doi: 10.1136/hrt.73.4.310

Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling.

J L Morris 1, A G Zaman 1, J H Smyllie 1, J C Cowan 1
PMCID: PMC483823  PMID: 7756063

Abstract

OBJECTIVE--To assess the possible benefits of intravenous isosorbide dinitrate in acute myocardial infarction and oral isosorbide mononitrate in subacute myocardial infarction. METHODS--316 patients presenting with acute myocardial infarction were entered into double blind placebo controlled clinical trials assessing infarct size by enzyme release, ventricular size and function by echocardiography, reperfusion by continuous 12 lead ST segment monitoring and late potentials by high resolution electrocardiography. RESULTS--301 patients, of whom 292 (97%) received thrombolytic treatment, were randomised on admission to intravenous isosorbide dinitrate or placebo. Overall, there was no significant effect of treatment on infarct size, ST segment resolution, ventricular remodelling, or late potentials at day 3. A trend was observed towards a reduction in infarct size in patients with non-Q wave infarction treated with isosorbide dinitrate. Heterogeneity of nitrate effect was observed in relation to the degree of ST segment elevation on presentation with a clear benefit of isosorbide dinitrate in patients with moderate ST segment elevation (472 U/l v 704 U/l, P = 0.003) and a trend towards a deleterious effect in patients with marked ST segment elevation (1152 U/l v 1058 U/l, P = 0.2). ST segment re-elevation was more common among patients receiving nitrate treatment than in those assigned to placebo (29 v 16, P < 0.05). Some 160 patients underwent a further randomisation to sustained release isosorbide mononitrate or placebo on day 3. Echocardiographic volumes after 6 weeks of treatment were similar in the two groups. CONCLUSIONS--No benefit was observed with administration of nitrates in the treatment groups as a whole for either acute or subacute infarction. There was, however, evidence of heterogeneity of effect in the different subgroups of acute infarction, and the possibility that nitrates may have differing actions in different groups of patients should be considered.

Full text

PDF
310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bossaert L., Conraads V., Pintens H. ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? The Belgian EMS Study Group. Eur Heart J. 1991 Mar;12(3):357–362. doi: 10.1093/oxfordjournals.eurheartj.a059902. [DOI] [PubMed] [Google Scholar]
  2. Breithardt G., Cain M. E., el-Sherif N., Flowers N. C., Hombach V., Janse M., Simson M. B., Steinbeck G. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circulation. 1991 Apr;83(4):1481–1488. doi: 10.1161/01.cir.83.4.1481. [DOI] [PubMed] [Google Scholar]
  3. Bussmann W. D., Passek D., Seidel W., Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation. 1981 Mar;63(3):615–622. doi: 10.1161/01.cir.63.3.615. [DOI] [PubMed] [Google Scholar]
  4. Flaherty J. T., Becker L. C., Bulkley B. H., Weiss J. L., Gerstenblith G., Kallman C. H., Silverman K. J., Wei J. Y., Pitt B., Weisfeldt M. L. A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation. 1983 Sep;68(3):576–588. doi: 10.1161/01.cir.68.3.576. [DOI] [PubMed] [Google Scholar]
  5. Geltman E. M., Ehsani A. A., Campbell M. K., Schechtman K., Roberts R., Sobel B. E. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation. 1979 Oct;60(4):805–814. doi: 10.1161/01.cir.60.4.805. [DOI] [PubMed] [Google Scholar]
  6. Habib G. B., Heibig J., Forman S. A., Brown B. G., Roberts R., Terrin M. L., Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991 Mar;83(3):739–746. doi: 10.1161/01.cir.83.3.739. [DOI] [PubMed] [Google Scholar]
  7. Hackett D., Davies G., Chierchia S., Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987 Oct 22;317(17):1055–1059. doi: 10.1056/NEJM198710223171704. [DOI] [PubMed] [Google Scholar]
  8. Hermens W. T., van der Veen F. H., Willems G. M., Mullers-Boumans M. L., Schrijvers-van Schendel A., Reneman R. S. Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog. Circulation. 1990 Feb;81(2):649–659. doi: 10.1161/01.cir.81.2.649. [DOI] [PubMed] [Google Scholar]
  9. Hildebrandt P., Torp-Pedersen C., Joen T., Iversen E., Jensen G., Jeppesen D., Melchior T., Schytten H. J., Ringsdal V., Jensen J. Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase. Am Heart J. 1992 Nov;124(5):1139–1144. doi: 10.1016/0002-8703(92)90392-9. [DOI] [PubMed] [Google Scholar]
  10. Jaffe A. S., Geltman E. M., Tiefenbrunn A. J., Ambos H. D., Strauss H. D., Sobel B. E., Roberts R. Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study. Br Heart J. 1983 May;49(5):452–460. doi: 10.1136/hrt.49.5.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jugdutt B. I., Becker L. C., Hutchins G. M., Bulkley B. H., Reid P. R., Kallman C. H. Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog. Circulation. 1981 Jan;63(1):17–28. doi: 10.1161/01.cir.63.1.17. [DOI] [PubMed] [Google Scholar]
  12. Jugdutt B. I. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation. 1983 Sep;68(3):673–684. doi: 10.1161/01.cir.68.3.673. [DOI] [PubMed] [Google Scholar]
  13. Jugdutt B. I., Warnica J. W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation. 1988 Oct;78(4):906–919. doi: 10.1161/01.cir.78.4.906. [DOI] [PubMed] [Google Scholar]
  14. Krucoff M. W., Croll M. A., Pope J. E., Granger C. B., O'Connor C. M., Sigmon K. N., Wagner B. L., Ryan J. A., Lee K. L., Kereiakes D. J. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation. 1993 Aug;88(2):437–446. doi: 10.1161/01.cir.88.2.437. [DOI] [PubMed] [Google Scholar]
  15. Krucoff M. W., Croll M. A., Pope J. E., Pieper K. S., Kanani P. M., Granger C. B., Veldkamp R. F., Wagner B. L., Sawchak S. T., Califf R. M. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 1993 Jan 15;71(2):145–151. doi: 10.1016/0002-9149(93)90729-v. [DOI] [PubMed] [Google Scholar]
  16. Mortelmans L., Vanhaecke J., Lesaffre E., Arnold A., Urbain J. L., Hermens W., De Roo M., De Geest H., Verstraete M., Van de Werf F. Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. Am Heart J. 1990 Jun;119(6):1231–1237. doi: 10.1016/s0002-8703(05)80169-3. [DOI] [PubMed] [Google Scholar]
  17. Pipilis A., Flather M., Collins R., Coats A., Conway M., Appleby P., Sleight P. Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study. J Am Coll Cardiol. 1993 Jul;22(1):73–79. doi: 10.1016/0735-1097(93)90817-k. [DOI] [PubMed] [Google Scholar]
  18. Rentrop K. P., Feit F., Sherman W., Stecy P., Hosat S., Cohen M., Rey M., Ambrose J., Nachamie M., Schwartz W. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol. 1989 Jul;14(1):58–64. doi: 10.1016/0735-1097(89)90054-5. [DOI] [PubMed] [Google Scholar]
  19. Sabia P. J., Powers E. R., Jayaweera A. R., Ragosta M., Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation. 1992 Jun;85(6):2080–2089. doi: 10.1161/01.cir.85.6.2080. [DOI] [PubMed] [Google Scholar]
  20. Sabia P. J., Powers E. R., Ragosta M., Sarembock I. J., Burwell L. R., Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992 Dec 24;327(26):1825–1831. doi: 10.1056/NEJM199212243272601. [DOI] [PubMed] [Google Scholar]
  21. Schiller N. B., Shah P. M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358–367. doi: 10.1016/s0894-7317(89)80014-8. [DOI] [PubMed] [Google Scholar]
  22. Shah P. K., Cercek B., Lew A. S., Ganz W. Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol. 1993 Jan;21(1):55–61. doi: 10.1016/0735-1097(93)90716-e. [DOI] [PubMed] [Google Scholar]
  23. Simoons M. L., Serruys P. W., van den Brand M., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Bär F., de Zwaan C., van der Laarse A. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol. 1986 Apr;7(4):717–728. doi: 10.1016/s0735-1097(86)80329-1. [DOI] [PubMed] [Google Scholar]
  24. Thompson P. L., Fletcher E. E., Katavatis V. Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction. Circulation. 1979 Jan;59(1):113–119. doi: 10.1161/01.cir.59.1.113. [DOI] [PubMed] [Google Scholar]
  25. Topol E. J., Califf R. M. Answers to complex questions cannot be derived from "simple" trials. Br Heart J. 1992 Oct;68(4):348–351. doi: 10.1136/hrt.68.10.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wahr D. W., Wang Y. S., Schiller N. B. Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population. J Am Coll Cardiol. 1983 Mar;1(3):863–868. doi: 10.1016/s0735-1097(83)80200-9. [DOI] [PubMed] [Google Scholar]
  27. Willems G. M., Visser M. P., Krill M. T., Hermens W. T. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes. Cardiovasc Res. 1982 Mar;16(3):120–131. doi: 10.1093/cvr/16.3.120. [DOI] [PubMed] [Google Scholar]
  28. Witteveen S. A., Hemker H. C., Hollaar L., Hermens W. T. Quantitation of infarct size in man by means of plasma enzyme levels. Br Heart J. 1975 Aug;37(8):795–803. doi: 10.1136/hrt.37.8.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]
  30. Zaman A. G., Morris J. L., Smyllie J. H., Cowan J. C. Late potentials and ventricular enlargement after myocardial infarction. A new role for high-resolution electrocardiography? Circulation. 1993 Sep;88(3):905–914. doi: 10.1161/01.cir.88.3.905. [DOI] [PubMed] [Google Scholar]
  31. de Zwaan C., Willems G. M., Vermeer F., Res J., Verheugt F. W., van der Laarse A., Simoons M. L., Lubsen J., Hermens W. T. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction. Br Heart J. 1988 Feb;59(2):175–183. doi: 10.1136/hrt.59.2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van der Laarse A., Hermens W. T., Hollaar L., Jol M., Willems G. M., Lemmers H. E., Liem A. H., Souverijn J. H., Oudhof J. H., de Hooge J. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J. 1984 Feb;107(2):248–260. doi: 10.1016/0002-8703(84)90372-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES